High Point Advisor Group LLC Astrazeneca PLC Transaction History
High Point Advisor Group LLC
- $2.05 Billion
- Q3 2025
A detailed history of High Point Advisor Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, High Point Advisor Group LLC holds 29,029 shares of AZN stock, worth $2.6 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
29,029
Previous 26,827
8.21%
Holding current value
$2.6 Million
Previous $1.87 Million
18.84%
% of portfolio
0.11%
Previous 0.1%
Shares
27 transactions
Others Institutions Holding AZN
# of Institutions
1,502Shares Held
500MCall Options Held
5.64MPut Options Held
3.2M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...